Glaxosmithkline plc - ADR

NYSE:GSK   3:59:59 PM EDT
-0.08 (-0.20%)
4:20:03 PM EDT: $39.08 +0.23 (+0.59%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)90.33B
Current PE17.83
Forward PE 13.83
2yr Forward PE 12.65
See more stats
Estimates Current Quarter
Revenue$12.07 Billion
Adjusted EPS$0.79
See more estimates
10-Day MA$39.56
50-Day MA$40.15
200-Day MA$37.34
See more pivots

Glaxosmithkline plc - ADR Stock, NYSE:GSK

980 Great West Road, Brentford, Middlesex, Greater London TW8 9GS
United Kingdom
Phone: +44.20.8047.5000
Number of Employees: 94066


GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.